COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S – Share repurchase programme

05/08/2019 - 13:41

Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 5 August 2019 – On 7 May 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European [...]

Minerva Neurosciences Reports Second Quarter 2019 Financial Results and Business Updates

05/08/2019 - 13:30

During the Second Quarter, Minerva announced several important clinical advancements, including positive top line results from two Phase 2b studies of seltorexant (MIN-202) in major depressive disorder (MDD) and [...]

Alkahest Announces Positive Top-line Data from Phase 2 Study in Mild to Moderate Alzheimer’s Disease

05/08/2019 - 13:30

SAN CARLOS, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Alkahest, Inc., a clinical-stage biotechnology company focused on developing transformative therapies to treat age-related diseases, today announced top-line data [...]

VIVUS Announces Approval of Qsymia® in the Republic of Korea

05/08/2019 - 13:30

VIVUS receives $2.5 million milestone payment CAMPBELL, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the “Company”), a biopharmaceutical company, announced today that its Korean marketing partner [...]

Kiniksa Pharmaceuticals Announces Collaboration with the Myocarditis Foundation for the Pericarditis Community

05/08/2019 - 13:30

HAMILTON, Bermuda, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic [...]

Intra-Cellular Therapies to Host Conference Call to Provide Regulatory Update Following Recent Meeting with FDA

05/08/2019 - 13:30

Agreement reached with FDA on submission of additional non-clinical information for NDA review of lumateperone for the treatment of schizophrenia Lumateperone PDUFA goal date extended three months to December 27, 2019 [...]

Theratechnologies’ CFO to Attend 39ᵗʰ Annual Growth Conference Held by Canaccord Genuity in Boston

05/08/2019 - 13:30

MONTREAL, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Philippe Dubuc, Senior Vice President and Chief Financial Officer, will attend the 39 th [...]

Le chef de la direction financière de Theratechnologies assistera à la 39ᵉ Annual Growth Conference tenue par Canaccord Genuity à Boston

05/08/2019 - 13:30

MONTRÉAL, 05 août 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que Philippe Dubuc, vice-président sénior et chef de la direction financière assistera à la 39 e [...]

Arbutus Reports Second Quarter 2019 Financial Results and Provides Corporate Update

05/08/2019 - 13:30

- Appointed William Collier , with decades of leadership experience in antivirals, President & CEO - Announced preliminary Phase 1a/1b clinical trial results demonstrating that AB-506 is a potent capsid inhibitor in [...]

BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)

05/08/2019 - 13:15

RESEARCH TRIANGLE PARK, N.C., Aug. 05, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted six newly-hired [...]

Allakos Reports Second Quarter 2019 Financial Results

05/08/2019 - 13:15

REDWOOD CITY, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing AK002 for the treatment of eosinophil and mast cell related diseases, today [...]

The Joint Corp. Increases Corporate Clinic Portfolio by Two, to Reach 57

05/08/2019 - 13:05

Acquires Clinic in South Carolina Market, Expanding New Corporate Market Opens Greenfield in El Cajon, Broadening the San Diego Portfolio SCOTTSDALE, Ariz., Aug. 05, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: [...]

Altimmune to Announce Second Quarter 2019 Financial Results on August 14

05/08/2019 - 13:00

GAITHERSBURG, Md., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical stage biopharmaceutical company focused on developing liver disease and immune modulating therapies, today announced that it [...]

FH Ortho Receives Regulatory Clearance in Japan for its Arrow® Prime Anatomic Shoulder System

05/08/2019 - 13:00

MULHOUSE, France, Aug. 05, 2019 (GLOBE NEWSWIRE) -- FH Ortho, a manufacturer of orthopedic devices and instruments for surgeons around the world, announced it has received approval from the Pharmaceuticals and Medical [...]

Invitation: Terveystalo H1 Result – Webcast and Conference Call on 8 August 2019

05/08/2019 - 13:00

Terveystalo Plc will publish its half-year report for 2019 on 8 August at 9:00 EEST. (Finnish time). Materials are available after publication at: https://www.terveystalo.com/en/investors/Financial-information/ [...]

Allakos Announces AK002 Met All Prespecified Primary and Secondary Endpoints in Phase 2 Randomized, Double-Blind, Placebo-Controlled Study in Patients with Eosinophilic Gastritis (EG) and/or Eosinophilic Gastroenteritis (EGE)

05/08/2019 - 13:00

Primary efficacy endpoint met with 95% reduction in gastrointestinal tissue eosinophils vs. 10% increase on placebo (p < 0.0001) Treatment response secondary endpoint met with 69% of AK002 treated patients meeting [...]

Arvinas Reports Second Quarter 2019 Financial Results and Provides Corporate Update

05/08/2019 - 13:00

NEW HAVEN, Conn., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, today reported financial results for the [...]

CADScor®System – Significantly more effective than current practice

05/08/2019 - 12:30

Press release Malmö August 5, 2019 CADScor®System – Significantly more effective than current practice Acarix AB (publ) (ACARIX: FN Stockholm) today announced the publication of a meta-analysis including 2245 patients [...]

Quotient Limited Provides Updates on European Hypercare Launch, the CE Mark Submission and U.S. Field Trial for the Initial Serological Disease Screening Microarray, and Reports First Quarter Fiscal 2020 Results

05/08/2019 - 12:15

First European hypercare launch site initiated following CE mark approval Initial Serological Disease Screening microarray submitted for CE marking U.S. field trial activities for initial Serological Disease Screening [...]